ACCESS Newswire 20 Apr 2026, 18:45 GMT+10 'MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20: 'Botanical Therapies Must Meet FDA Standards-Not Political Timelines' said Duane Boise MMJ International Holdings CEO. / ACCESS Newswire / April 20, 2026 / On a day traditionally associated with cannabis advocacy, MMJ International Holdings announced its support for litigation aligned with Smart Approaches to Marijuana et al challenging the Centers for Medicare & Medicaid Services' cannabinoid reimbursement framework, warning that federal healthcare dollars should not be used to introduce unvalidated botanical products into the Medicare population. The company's position is clear: Botanical therapies must meet reproducibility, safety, and clinical-trial standards before federal adoption. MMJ International Holdings is supporting the legal effort alongside nationally recognized pain specialist Kenneth Finn, M.D., and constitutional attorney Ilya Shapiro of Burke Law Group, who are raising concerns about the scientific and
Latest development
Media Coverage · April 20, 2026
MMJ International Holdings joined a federal lawsuit against the Centers for Medicare & Medicaid Services (CMS) on April 20, 2026, challenging a CMS program that would reimburse hemp-derived cannabinoid products for Medicare patients before those products clear Food and Drug Administration (FDA) validation. The plaintiffs — which include the group Smart Approaches to Marijuana, pain specialist Kenneth Finn, M.D., and
newspaper Read articleACCESS Newswire 20 Apr 2026, 18:45 GMT+10 'MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20: 'Botanical Therapies Must Meet FDA Standards-Not Political Timelines' said Duane Boise MMJ International Holdings CEO. / ACCESS Newswire / April 20, 2026 / On a day traditionally associated with cannabis advocacy, MMJ International Holdings announced its support for litigation aligned with Smart Approaches to Marijuana et al challenging t
Open original open_in_newJuryvine summaries are generated from court records. Expand "Source" on any row to see the underlying filing.
MMJ International Holdings joined a federal lawsuit against the Centers for Medicare & Medicaid Services (CMS) on April 20, 2026, challenging a CMS program that would reimburse hemp-derived cannabinoid products for Medicare patients before those products clear Food and Drug Administration (FDA) validation. The plaintiffs — which include the group Smart Approaches to Marijuana, pain specialist Kenneth Finn, M.D., and constitutional attorney Ilya Shapiro of Burke Law Group — argue that CMS is opening a federal reimbursement pathway for botanical products that have not met reproducibility, safety, or clinical-trial standards. No docket number is publicly available from this press release.
ACCESS Newswire 20 Apr 2026, 18:45 GMT+10 'MMJ International Holdings Joins Smart Approaches to Marijuana et al, Federal Challenge to CMS Hemp Program on 4/20: 'Botanical Therapies Must Meet FDA …
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
4 hours, 25 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.